414 related articles for article (PubMed ID: 24603732)
21. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles.
Souza KP; Luz JA; Teles SA; Carneiro MA; Oliveira LA; Gomes AS; Dias MA; Gomes SA; Yoshida CF; Martins RM
Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):599-603. PubMed ID: 13677340
[TBL] [Abstract][Full Text] [Related]
22. Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil.
Silva CM; Costi C; Costa C; Michelon C; Oravec R; Ramos AB; Niel C; Rossetti ML
J Infect; 2005 Jul; 51(1):24-9. PubMed ID: 15979486
[TBL] [Abstract][Full Text] [Related]
23. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
[TBL] [Abstract][Full Text] [Related]
24. Characterization of overt and occult hepatitis B virus infection among HTLV-1 positive healthy carriers in the Northeast of Iran; AN HTLV-I endemic area.
Chenari M; Norouzi M; Ghalichi L; Rezaee A; Yari A; Alavian SM; Jazayeri SM
J Med Virol; 2014 Nov; 86(11):1861-7. PubMed ID: 25132488
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B virus screening in contacts of blood donors with antibodies against core protein (anti-HBC), but without surface antigen (HBsAg).
Fortes HM; Ribeiro LC; Perazolo GF; Souto FJ
Mem Inst Oswaldo Cruz; 2006 Mar; 101(2):195-9. PubMed ID: 16830712
[TBL] [Abstract][Full Text] [Related]
26. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of "anti-HBc alone" among Syrian blood donors.
Muselmani W; Habbal W; Monem F
J Infect Dev Ctries; 2014 Aug; 8(8):1013-5. PubMed ID: 25116667
[TBL] [Abstract][Full Text] [Related]
28. Occult hepatitis B virus infection in Korean patients with isolated anti-HBc.
Kang SY; Kim MH; Lee WI
Arch Virol; 2014 Feb; 159(2):227-33. PubMed ID: 23933720
[TBL] [Abstract][Full Text] [Related]
29. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination.
Lai MW; Lin TY; Tsao KC; Huang CG; Hsiao MJ; Liang KH; Yeh CT
Gastroenterology; 2012 Aug; 143(2):400-7. PubMed ID: 22580098
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
31. Occult hepatitis B virus infection: implications in transfusion.
Allain JP
Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B virus infection in a population exposed to occupational hazards: firefighters of a metropolitan region in central Brazil.
Contrera-Moreno L; de Andrade SM; Pontes ER; Stief AC; Pompilio MA; Motta-Castro AR
Rev Soc Bras Med Trop; 2012; 45(4):463-7. PubMed ID: 22930044
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B and C virus infection among Brazilian Amazon riparians.
Oliveira CS; Silva AV; Dos Santos KN; Fecury AA; Almeida MK; Fernandes AP; Costa CA; Freitas AS; Corvelo TC; Martins LC
Rev Soc Bras Med Trop; 2011 Oct; 44(5):546-50. PubMed ID: 22031069
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of hepatitis B virus and risk factors in Brazilian non-injecting drug users.
Ferreira RC; Rodrigues FP; Teles SA; Lopes CL; Motta-Castro AR; Novais AC; Souto FJ; Martins RM
J Med Virol; 2009 Apr; 81(4):602-9. PubMed ID: 19235862
[TBL] [Abstract][Full Text] [Related]
35. Overt and occult hepatitis B virus infection among treatment-naïve HIV-infected patients in Brazil.
Oliveira MP; Lemes PS; Matos MA; Del-Rios NH; Carneiro MA; Silva ÁM; Lopes CL; Teles SA; Aires RS; Lago BV; Araujo NM; Martins RM
J Med Virol; 2016 Jul; 88(7):1222-9. PubMed ID: 27061406
[TBL] [Abstract][Full Text] [Related]
36. Isolated core antibody hepatitis B in sub-Saharan African immigrants.
Gibney KB; Torresi J; Lemoh C; Biggs BA
J Med Virol; 2008 Sep; 80(9):1565-9. PubMed ID: 18649341
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B virus infection profile in hemodialysis patients in Central Brazil: prevalence, risk factors, and genotypes.
Ferreira RC; Teles SA; Dias MA; Tavares VR; Silva SA; Gomes SA; Yoshida CF; Martins RM
Mem Inst Oswaldo Cruz; 2006 Sep; 101(6):689-92. PubMed ID: 17072485
[TBL] [Abstract][Full Text] [Related]
38. Donor screening for hepatitis B virus infection in a cell and tissue bank.
Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
[TBL] [Abstract][Full Text] [Related]
39. High prevalence of active and occult hepatitis B virus infections in healthcare workers from two provinces of South Africa.
Sondlane TH; Mawela L; Razwiedani LL; Selabe SG; Lebelo RL; Rakgole JN; Mphahlele MJ; Dochez C; De Schryver A; Burnett RJ
Vaccine; 2016 Jul; 34(33):3835-9. PubMed ID: 27265453
[TBL] [Abstract][Full Text] [Related]
40. PREVALENCE OF OCCULT HEPATITIS B INFECTION IN IRANIAN CANCER PATIENTS BEFORE CHEMOTHERAPY TREATMENT.
Baghbanian M; Halvani M; Roghani HS; Lotfi MH; Yazdi MF; Vahedian-Ardakani HA
Arq Gastroenterol; 2016; 53(3):175-9. PubMed ID: 27438423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
